Annual Accounts Receivable
$15.22 M
-$12.99 M-46.04%
December 31, 2023
Summary
- As of February 8, 2025, FBIO annual accounts receivable is $15.22 million, with the most recent change of -$12.99 million (-46.04%) on December 31, 2023.
- During the last 3 years, FBIO annual accounts receivable has fallen by -$8.71 million (-36.38%).
- FBIO annual accounts receivable is now -46.04% below its all-time high of $28.21 million, reached on December 31, 2022.
Performance
FBIO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$10.67 M
+$206.00 K+1.97%
September 30, 2024
Summary
- As of February 8, 2025, FBIO quarterly accounts receivable is $10.67 million, with the most recent change of +$206.00 thousand (+1.97%) on September 30, 2024.
- Over the past year, FBIO quarterly accounts receivable has increased by +$2.68 million (+33.57%).
- FBIO quarterly accounts receivable is now -66.38% below its all-time high of $31.74 million, reached on September 30, 2021.
Performance
FBIO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
FBIO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.0% | +33.6% |
| 3 y3 years | -36.4% | -53.8% |
| 5 y5 years | +176.9% | -31.8% |
FBIO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.0% | at low | -65.8% | +33.6% |
| 5 y | 5-year | -46.0% | +12.4% | -66.4% | +33.6% |
| alltime | all time | -46.0% | -100.0% | -66.4% | -100.0% |
Fortress Biotech Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.67 M(+2.0%) |
| Jun 2024 | - | $10.46 M(+6.8%) |
| Mar 2024 | - | $9.80 M(-35.6%) |
| Dec 2023 | $15.22 M(-46.0%) | $15.22 M(+90.5%) |
| Sep 2023 | - | $7.99 M(-52.3%) |
| Jun 2023 | - | $16.74 M(-39.4%) |
| Mar 2023 | - | $27.62 M(-2.1%) |
| Dec 2022 | $28.21 M(+22.0%) | $28.21 M(-1.1%) |
| Sep 2022 | - | $28.53 M(-0.5%) |
| Jun 2022 | - | $28.67 M(-8.1%) |
| Mar 2022 | - | $31.18 M(+34.9%) |
| Dec 2021 | $23.11 M(-3.4%) | $23.11 M(-27.2%) |
| Sep 2021 | - | $31.74 M(+21.2%) |
| Jun 2021 | - | $26.19 M(+34.7%) |
| Mar 2021 | - | $19.44 M(-18.8%) |
| Dec 2020 | $23.93 M | $23.93 M(+52.9%) |
| Sep 2020 | - | $15.65 M(+40.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $11.17 M(-29.3%) |
| Mar 2020 | - | $15.81 M(+16.8%) |
| Dec 2019 | $13.54 M(+146.3%) | $13.54 M(+163.6%) |
| Sep 2019 | - | $5.14 M(+65.5%) |
| Jun 2019 | - | $3.10 M(-61.3%) |
| Mar 2019 | - | $8.02 M(+45.9%) |
| Dec 2018 | $5.50 M(-29.1%) | $5.50 M(+1.2%) |
| Sep 2018 | - | $5.43 M(+2.1%) |
| Jun 2018 | - | $5.32 M(-36.0%) |
| Mar 2018 | - | $8.31 M(+7.2%) |
| Dec 2017 | $7.76 M(+323.9%) | $7.76 M(+39.0%) |
| Sep 2017 | - | $5.58 M(+67.3%) |
| Jun 2017 | - | $3.34 M(+143.9%) |
| Mar 2017 | - | $1.37 M(-25.2%) |
| Dec 2016 | $1.83 M(>+9900.0%) | $1.83 M(-63.5%) |
| Sep 2016 | - | $5.01 M(+417.8%) |
| Jun 2016 | - | $967.00 K(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00 |
FAQ
- What is Fortress Biotech annual accounts receivable?
- What is the all time high annual accounts receivable for Fortress Biotech?
- What is Fortress Biotech annual accounts receivable year-on-year change?
- What is Fortress Biotech quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Fortress Biotech?
- What is Fortress Biotech quarterly accounts receivable year-on-year change?
What is Fortress Biotech annual accounts receivable?
The current annual accounts receivable of FBIO is $15.22 M
What is the all time high annual accounts receivable for Fortress Biotech?
Fortress Biotech all-time high annual accounts receivable is $28.21 M
What is Fortress Biotech annual accounts receivable year-on-year change?
Over the past year, FBIO annual accounts receivable has changed by -$12.99 M (-46.04%)
What is Fortress Biotech quarterly accounts receivable?
The current quarterly accounts receivable of FBIO is $10.67 M
What is the all time high quarterly accounts receivable for Fortress Biotech?
Fortress Biotech all-time high quarterly accounts receivable is $31.74 M
What is Fortress Biotech quarterly accounts receivable year-on-year change?
Over the past year, FBIO quarterly accounts receivable has changed by +$2.68 M (+33.57%)